Table 1.
Total | Usual care | SDM toolkit | |||||
---|---|---|---|---|---|---|---|
n | % | n | % | n | % | p-value† | |
Total | 746 | 625 | 83.8 | 121 | 16.2 | ||
Age, mean (SD) | 8.55 | 4.2 | 8.52 | 4.1 | 8.74 | 4.5 | 0.596 |
Race/ethnicity | <0.001 | ||||||
Caucasian | 58 | 7.8 | 55 | 8.8 | 3 | 2.5 | |
African American | 404 | 54.2 | 338 | 54.1 | 66 | 54.5 | |
Hispanic/latino | 158 | 21.2 | 113 | 18.1 | 45 | 37.2 | |
Other | 126 | 16.9 | 119 | 19.0 | 7 | 5.8 | |
Insurance | 0.105 | ||||||
Commercial | 98 | 13.1 | 88 | 14.1 | 10 | 8.3 | |
Medicaid/other‡ | 648 | 86.9 | 537 | 85.9 | 111 | 91.7 | |
Gender | 0.295 | ||||||
Male | 451 | 60.5 | 383 | 61.3 | 68 | 56.2 | |
Female | 295 | 39.5 | 242 | 38.7 | 53 | 43.8 | |
Comorbidities | |||||||
Obesity | 71 | 9.5 | 55 | 8.8 | 16 | 13.2 | 0.035 |
Development delay | 9 | 1.2 | 8 | 1.3 | 1 | 0.8 | 1.000 |
Upper respiratory tract infection | 23 | 3.1 | 17 | 2.7 | 6 | 5.0 | 0.243 |
Rhinitis | 27 | 3.6 | 24 | 3.8 | 3 | 2.5 | 0.601 |
Baseline ED visits, mean (SD) | 0.23 | 0.6 | 0.20 | 0.6 | 0.39 | 0.7 | 0.005 |
Baseline inpatient visits, mean (SD) | 0.14 | 0.5 | 0.14 | 0.5 | 0.13 | 0.4 | 0.821 |
Baseline oral steroid use, mean (SD) | 0.43 | 0.9 | 0.42 | 0.9 | 0.50 | 0.9 | 0.336 |
Percentage of patients with poverty, mean (SD) | 0.24 | 0.1 | 0.23 | 0.1 | 0.24 | 0.1 | 0.654 |
Percentage of patients with education less than high school, mean (SD) | 0.21 | 0.1 | 0.21 | 0.1 | 0.22 | 0.1 | 0.258 |
Median follow-up (month) | 30.45 | 31.60 | 27.10 | <0.001 |
Note.
Based on Student’s t-test, Wilcoxon rank sum test, and Chi-square/Fisher’s exact test.
Other includes other public insurance and uninsured.